Glycyrrhiza lepidota
Glycyrrhiza lepidota · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Glycyrrhiza lepidota, commonly known as American licorice, is a botanical species recognized for its diverse pharmacological potential. Researchers have identified specific bioactive compounds within the plant, most notably the chemicals Glepidotin A and Glepidotin B. When the leaf is processed into an organic soluble extract, these constituents become highly accessible for therapeutic study. Recent investigations suggest that these extracts may play a role in addressing psychological conditions such as depression. Consequently, this plant represents a significant subject of interest in the search for natural medicinal alternatives.
- Synonyms
- Glycyrrhiza Lepidota Var. Glutinosa · Glycyrrhiza Glutinosa
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Common Names
Glycyrrhiza lepidota is a versatile plant known by several distinct regional and linguistic names. In English-speaking areas, it is frequently referred to as American Liquorice, American licorice, or American wild licorice. Its identity shifts across borders, appearing as Ameriski słódnik in certain contexts. In other regions, the plant is recognized by the name Yabani Meyan. These varied common names highlight the widespread recognition of this species across different cultures.
Sources: Catalogue of Life (COL)
Synonyms
Glycyrrhiza lepidota is a plant species that is frequently identified through various taxonomic designations in botanical literature. One common synonym for this species is Glycyrrhiza glutinosa, which can sometimes lead to confusion in scientific records. Furthermore, the taxon is also associated with the specific variety known as Glycyrrhiza lepidota var. glutinosa. Recognizing these overlapping names is essential for researchers studying the plant's genetic and morphological diversity. Understanding these nomenclatural relationships ensures clarity when documenting the species across different botanical databases.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Glycyrrhiza lepidota belongs to the vast kingdom Plantae, representing a diverse group of multicellular organisms. Within this kingdom, the plant is classified under the class Equisetopsida. It specifically falls into the order Fabales, which helps define its evolutionary lineage. Further narrowing its identity, the species is a member of the Fabaceae family. Finally, it is categorized under the genus Glycyrrhiza, completing its unique botanical profile.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Glycyrrhiza |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Glycyrrhiza lepidota is a resilient species widely distributed across various regions of North America. Its presence extends from the eastern reaches of Canada, including Ontario, down through the northeastern parts of Mexico. Within the United States, the plant is prominently found throughout the North-Central region. Specifically, it thrives in the landscapes of Illinois, Iowa, and Kansas. This broad geographic range highlights the plant's ability to adapt to diverse environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Glycyrrhiza lepidota is a self-supporting herb characterized by its sturdy growth form. This plant typically reaches a maximum height of 1.2 meters in its natural habitat. Its structural integrity allows it to stand upright while maintaining a consistent presence in the landscape.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Glycyrrhiza lepidota is a plant species that serves as a rich source of various bioactive chemical compounds. Scientific analysis of its organic soluble leaf extracts has led to the successful isolation of specific diprenylated bibenzyls. Among the constituents identified within the plant are the known compounds glepidotin A and glepidotin B. While these specific substances are present in the extract, research indicates they remain inactive in anti-HIV-1 bioassays. This distinction helps researchers differentiate these existing compounds from newer, active molecules found within the same species.
Conditions
Glycyrrhiza lepidota contains an organic soluble extract from its leaves that demonstrates moderate activity against HIV-1. Researchers identified a specific new diprenylated bibenzyl within this plant as the compound responsible for its anti-viral properties. Beyond its potential anti-viral effects, the broader study of medicinal plants explores various species used in the clinical treatment of depression. While the provided text highlights plants like saffron and St. John's wort for their antidepressant properties, the research context links medicinal plants to the management of such psychological syndromes. Together, these studies investigate how specific plant compounds can target both viral infections and complex neurological conditions.
Preparations
Glycyrrhiza lepidota is prepared as an organic soluble extract specifically from its leaves to facilitate biochemical study. This organic soluble extract was utilized in a US National Cancer Institute in vitro anti-HIV-1 bioassay to test for medicinal potential. Through chromatographic separation of this preparation, researchers were able to identify a new diprenylated bibenzyl. This specific compound within the organic soluble extract was responsible for the observed anti-viral activity. The extraction process also allowed for the isolation of known compounds, such as glepidotin A and B, from the plant material.
Parts used
Glycyrrhiza lepidota is a plant species of significant interest due to the unique chemical properties found within its biological components. Specifically, researchers have focused their attention on the leaf, which serves as a rich source of bioactive compounds. During recent investigations, an organic soluble extract was derived from these leaves to test for potential medicinal applications. This extraction process led to the identification of a new diprenylated bibenzyl that exhibits moderate anti-HIV-1 activity. Such findings highlight the importance of studying the specific parts of this plant to uncover novel antiviral agents.